A Phase I/II Trial of ALETA-001 for the Treatment of Participants With B-cell Malignancies

NCT06045910 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

RECRUITING

Status

84

Enrollment

OTHER

Sponsor class

Conditions

Lymphoma, Non-Hodgkin
Lymphoma, Large B-Cell, Diffuse
Lymphoma, Mantle-Cell
Lymphoma, Follicular
Lymphoma, B-Cell
Large B-cell Lymphoma

Interventions

DRUG: ALETA-001

Sponsor

Cancer Research UK

Collaborators

[object Object]